Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published January 11, 2022 | Version v1
Dataset Open

Screening of 67 compounds with predicted biosignature profile similar to remdesivir for anti-SARS-CoV-2 activity

  • 1. Janssen Pharmaceutica NV

Description

This short report describes the most relevant results of screening compounds with a similar predicted biosignature as remdesivir in a VeroE6 cell-based anti-SARS-CoV-2 assay.

Files